FUSION BIOVENTURE
Live / Registered — Registered (as of 28 Mar 2023)
What this means for you
Registered since 28 Mar 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97276885
- Registration number
- 7011432
- Mark type
- Stylized text
- Filed
- 21 Feb 2022
- Published for opposition
- 10 Jan 2023
- Registered
- 28 Mar 2023
- Attorney of record
- Perry Gattegno
Goods and services
- Class 036 — Insurance and financial services: Providing venture capital, development capital, private equity and investment funding; Venture capital services, namely, providing financing to emerging and start-up companies
- Class 042 — Scientific and technological services: Consulting services in the field of biotechnology; Consulting services in the field of pharmaceutical research and development; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Biochemical research and development; Consulting services in the field of pharmacogenetics; Pharmaceutical research and development; Scientific research and development; Vaccine research and development
Owner
- Fosun Pharma USA Inc., Lexington, MA, US
- Fosun Pharma USA Inc., Lexington, MA, US
- Fosun Pharma USA Inc., Lexington, MA, US
Prosecution history
- 28 Mar 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 28 Mar 2023 — REGISTERED-PRINCIPAL REGISTER
- 10 Jan 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Jan 2023 — PUBLISHED FOR OPPOSITION
- 21 Dec 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 06 Dec 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 05 Dec 2022 — ASSIGNED TO EXAMINER
- 24 Feb 2022 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 24 Feb 2022 — NEW APPLICATION ENTERED